Cue Domain-Containing Protein 2 Promotes the Warburg Effect and Tumorigenesis

Xiuying Zhong,Shengya Tian,Xiang Zhang,Xinwei Diao,Fangting Dong,Jie Yang,Zhaoyong Li,Linchong Sun,Lin Wang,Xiaoping He,Gongwei Wu,Xin Hu,Lihua Wang,Libing Song,Huafeng Zhang,Xin Pan,Ailing Li,Ping Gao

DOI: https://doi.org/10.15252/embr.201643617

IF: 9.071

2017-01-01

EMBO Reports

Abstract:Cancer progression depends on cellular metabolic reprogramming as both direct and indirect consequence of oncogenic lesions; however, the underlying mechanisms are still poorly understood. Here, we report that CUEDC2 ( CUEdomain-containing protein 2) plays a vital role in facilitating aerobic glycolysis, or Warburg effect, in cancer cells. Mechanistically, we show that CUEDC2 upregulates the two key glycolytic proteins GLUT3 and LDHA via interacting with the glucocorticoid receptor (GR) or 14-3-3 zeta, respectively. We further demonstrate that enhanced aerobic glycolysis is essential for the role of CUEDC2 to drive cancer progression. Moreover, using tissue microarray analysis, we show a correlation between the aberrant expression of CUEDC2, and GLUT3 and LDHA in clinical HCC samples, further demonstrating a link between CUEDC2 and the Warburg effect during cancer development. Taken together, our findings reveal a previously unappreciated function of CUEDC2 in cancer cell metabolism and tumorigenesis, illustrating how close oncogenic lesions are intertwined with metabolic alterations promoting cancer progression.